A recent review published in The Lancet confirms the high effectiveness of mRNA vaccines in preventing severe disease and serious side effects. The study highlights their adaptability for future medical applications, including cancer treatment, while emphasizing the need for equitable access in low-income regions. Researchers advocate for increased manufacturing capacity and investment in local production to ensure global health equity.